MARIA JESUS
SANZ FERRANDO
CATEDRÀTIC/A D'UNIVERSITAT
Instituto de Salud Carlos III
Madrid, EspañaPublications in collaboration with researchers from Instituto de Salud Carlos III (8)
2023
-
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease
International Journal of Molecular Sciences, Vol. 24, Núm. 3
2021
-
Peripheral blood levels of CXCL10 are a useful marker for diabetic polyneuropathy in subjects with type 2 diabetes
International Journal of Clinical Practice, Vol. 75, Núm. 8
2010
-
Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-γ upregulation
Journal of Immunology, Vol. 185, Núm. 6, pp. 3718-3727
2009
-
Budlein A from Viguiera robusta inhibits leukocyte-endothelial cell interactions, adhesion molecule expression and inflammatory mediators release
Phytomedicine, Vol. 16, Núm. 10, pp. 904-915
2008
-
Leukotriene B4-loaded microspheres: A new therapeutic strategy to modulate cell activation
BMC Immunology, Vol. 9
-
Prostaglandin E2-loaded microspheres as strategy to inhibit phagocytosis and modulate inflammatory mediators release
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 70, Núm. 3, pp. 784-790
2007
-
A critical role for TNFα in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles
Blood, Vol. 110, Núm. 6, pp. 1895-1902
-
Roflumilast inhibits leukocyte-endothelial cell interactions, expression of adhesion molecules and microvascular permeability
British Journal of Pharmacology, Vol. 152, Núm. 4, pp. 481-492